Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma

Blood. 2020 May 14;135(20):1811-1815. doi: 10.1182/blood.2019003073.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Drug-Related Side Effects and Adverse Reactions / epidemiology
  • Eye Neoplasms / drug therapy*
  • Eye Neoplasms / epidemiology
  • Eye Neoplasms / pathology
  • Female
  • Humans
  • Lymphoma / drug therapy*
  • Lymphoma / epidemiology
  • Lymphoma / pathology
  • Male
  • Middle Aged
  • Retinal Neoplasms / drug therapy*
  • Retinal Neoplasms / epidemiology
  • Retinal Neoplasms / pathology
  • Retrospective Studies
  • Temozolomide / therapeutic use*
  • Treatment Outcome
  • Vitreous Body / pathology

Substances

  • Temozolomide